| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.ACTBIO.2017.02.008 |
| P698 | PubMed publication ID | 28185909 |
| P2093 | author name string | Lawrence J Bonassar | |
| Izath Nizeet Aguilar | |||
| Shuiliang Shi | |||
| Stephen Trippel | |||
| P2860 | cites work | Structure of the IGF-binding domain of the insulin-like growth factor-binding protein-5 (IGFBP-5): implications for IGF and IGF-I receptor interactions | Q24533385 |
| The interaction of insulin-like growth factor-I with the N-terminal domain of IGFBP-5 | Q27633115 | ||
| Matrix Gla protein (MGP) and bone morphogenetic protein-2 in aortic calcified lesions of aging rats | Q28569577 | ||
| Recombinant MG53 protein modulates therapeutic cell membrane repair in treatment of muscular dystrophy | Q30545559 | ||
| Enhanced in vitro chondrogenesis of primary mesenchymal stem cells by combined gene transfer | Q33606440 | ||
| Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease | Q33726762 | ||
| Tissue engineering via local gene delivery | Q34042830 | ||
| Intraarticular injection of heparin-binding insulin-like growth factor 1 sustains delivery of insulin-like growth factor 1 to cartilage through binding to chondroitin sulfate | Q34367377 | ||
| Biomaterials in the repair of sports injuries | Q84603765 | ||
| Binding and release characteristics of insulin-like growth factor-1 from a collagen-glycosaminoglycan scaffold | Q34414870 | ||
| Plasmid-encapsulated polyethylene glycol-grafted polyethylenimine nanoparticles for gene delivery into rat mesenchymal stem cells | Q34956388 | ||
| Fluorometric assay of DNA in cartilage explants using Hoechst 33258. | Q35124134 | ||
| Osteoarthritis gene therapy | Q35629588 | ||
| IGF-I is a matter of heart | Q36088842 | ||
| Extracellular matrix contains insulin-like growth factor binding protein-5: potentiation of the effects of IGF-I | Q36232491 | ||
| Large-scale chondroitin sulfate proteoglycan digestion with chondroitinase gene therapy leads to reduced pathology and modulates macrophage phenotype following spinal cord contusion injury | Q37679296 | ||
| Advances and challenges in gene-based approaches for osteoarthritis | Q38134331 | ||
| Presentation of BMP-2 mimicking peptides in 3D hydrogels directs cell fate commitment in osteoblasts and mesenchymal stem cells. | Q39277375 | ||
| Benefits of recombinant adeno-associated virus (rAAV)-mediated insulinlike growth factor I (IGF-I) overexpression for the long-term reconstruction of human osteoarthritic cartilage by modulation of the IGF-I axis | Q39676689 | ||
| Comparison of Efficacy of Endogenous and Exogenous IGF-I in Stimulating Matrix Production in Neonatal and Mature Chondrocytes. | Q40479463 | ||
| Distinctive patterns of PDGF-A, FGF-2, IGF-I, and TGF-beta1 gene expression during remyelination of experimentally-induced spinal cord demyelination. | Q40792686 | ||
| Alginate hydrogels as synthetic extracellular matrix materials | Q40978578 | ||
| Rediscovering an old friend, IGF-I: potential use in the treatment of neurodegenerative diseases | Q41553648 | ||
| Effect of transfection strategy on growth factor overexpression by articular chondrocytes | Q41846147 | ||
| Effect of media mixing on ECM assembly and mechanical properties of anatomically-shaped tissue engineered meniscus | Q42227683 | ||
| Inhibition of cartilage degradation: a combined tissue engineering and gene therapy approach | Q42438194 | ||
| The effect of dynamic compression on the response of articular cartilage to insulin-like growth factor-I. | Q43595017 | ||
| Exogenous insulin-like growth factor-I stimulates an autoinductive IGF-I autocrine/paracrine response in chondrocytes | Q43595031 | ||
| Gene mediated insulin-like growth factor-I delivery to the synovium | Q43741092 | ||
| Quaternized chitosan oligomers as novel gene delivery vectors in epithelial cell lines | Q43837302 | ||
| Menisci are efficiently transduced by recombinant adeno-associated virus vectors in vitro and in vivo | Q44019074 | ||
| Sustained transgene expression in cartilage defects in vivo after transplantation of articular chondrocytes modified by lipid-mediated gene transfer in a gel suspension delivery system | Q44036702 | ||
| The differentiation of bone marrow mesenchymal stem cells into chondrocyte-like cells on poly-L-lactic acid (PLLA) scaffolds | Q44205732 | ||
| Transfection of primary chondrocytes using chitosan-pEGFP nanoparticles | Q44316476 | ||
| Effect of substrate mechanics on chondrocyte adhesion to modified alginate surfaces | Q44753777 | ||
| Recombinant adeno-associated virus vectors efficiently and persistently transduce chondrocytes in normal and osteoarthritic human articular cartilage | Q45728584 | ||
| Enhanced local delivery with reduced systemic toxicity: delivery, delivery, and delivery. | Q45865369 | ||
| Genetic modification of chondrocytes with insulin-like growth factor-1 enhances cartilage healing in an equine model | Q45868543 | ||
| Highly efficient cell-mediated gene transfer using non-viral vectors and FuGene6: in vitro and in vivo studies | Q45871556 | ||
| Remission in models of type 1 diabetes by gene therapy using a single-chain insulin analogue | Q45872828 | ||
| Direct adenovirus-mediated insulin-like growth factor I gene transfer enhances transplant chondrocyte function | Q45874375 | ||
| Overexpression of human insulin-like growth factor-I promotes new tissue formation in an ex vivo model of articular chondrocyte transplantation | Q45880338 | ||
| Enhanced repair of articular cartilage defects in vivo by transplanted chondrocytes overexpressing insulin-like growth factor I (IGF-I). | Q45882616 | ||
| Serum insulin-like growth factor I regulates brain amyloid-beta levels | Q48454367 | ||
| Quantification of sulfated glycosaminoglycans in chondrocyte/alginate cultures, by use of 1,9-dimethylmethylene blue. | Q50533827 | ||
| Porous chitosan-gelatin scaffold containing plasmid DNA encoding transforming growth factor-beta1 for chondrocytes proliferation. | Q51360083 | ||
| A tetracycline expression system in combination with Sox9 for cartilage tissue engineering. | Q53657646 | ||
| Controlled growth factor release from synthetic extracellular matrices | Q59086493 | ||
| Thrombospondin binds and activates the small and large forms of latent transforming growth factor-beta in a chemically defined system | Q72724754 | ||
| Anticoagulantly active heparin-like molecules from vascular tissue | Q72814587 | ||
| Incorporation of adhesion peptides into nonadhesive hydrogels useful for tissue resurfacing | Q74148784 | ||
| Controlled-release of IGF-I and TGF-beta1 in a photopolymerizing hydrogel for cartilage tissue engineering | Q77460826 | ||
| Enhanced repair of extensive articular defects by insulin-like growth factor-I-laden fibrin composites | Q78165069 | ||
| Local stimulation of articular cartilage repair by transplantation of encapsulated chondrocytes overexpressing human fibroblast growth factor 2 (FGF-2) in vivo | Q81051748 | ||
| Nano-carrier for gene delivery and bioimaging based on carbon dots with PEI-passivation enhanced fluorescence | Q83461572 | ||
| P921 | main subject | gene therapy | Q213901 |
| P304 | page(s) | 260-267 | |
| P577 | publication date | 2017-02-06 | |
| P1433 | published in | Acta Biomaterialia | Q4676719 |
| P1476 | title | Customized biomaterials to augment chondrocyte gene therapy | |
| P478 | volume | 53 |
Search more.